MITK Q1 2026 Earnings EPS Beat Sent Shares Higher Amid Strong Operational Execution BRCB Q1 2026 Earnings EPS Misses Estimates Yet Stock Rises on Operational Stability ETOR Q1 2026 Earnings EPS Surges Past Estimates by 234 Revenue Details Remain Undisclosed ABUS Q1 2026 Earnings Wider Loss Than Expected as Biotech Reports No Revenue Amneal Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency RCON Q4 2025 Earnings NarrowerThanExpected Loss Drives Optimism Despite Revenue Void